ICPT
Intercept Pharmaceuticals Inc
Price:  
19.00 
USD
Volume:  
3,906,760.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICPT WACC - Weighted Average Cost of Capital

The WACC of Intercept Pharmaceuticals Inc (ICPT) is 7.0%.

The Cost of Equity of Intercept Pharmaceuticals Inc (ICPT) is 8.45%.
The Cost of Debt of Intercept Pharmaceuticals Inc (ICPT) is 5.00%.

Range Selected
Cost of equity 7.30% - 9.60% 8.45%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.2% - 7.8% 7.0%
WACC

ICPT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.75 0.85
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 9.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.42 0.42
Cost of debt 5.00% 5.00%
After-tax WACC 6.2% 7.8%
Selected WACC 7.0%